The Uncorrected Proofs
IMPORTANT TO KNOW
After the authors have received the letter of acceptance and have paid the publication fee, the uncorrected version of their article appears instantly on our web site. It provides DOI and dates of acceptance and online posting.
This „early bird“ version of the article has been made available at this early stage in order to provide the fastest access to the article and is not intended to be the final version. The manuscript will undergo copyediting, typesetting and review of the resulting proof before it is published in its final form. To be noted that changes to the article should not be requested at this stage; for the proofreading the authors will be contacted by the Editor. This first version of the article will be replaced by the final version as soon as the latter becomes available and moved from „Uncorrected proofs“ to the „Papers in press“.
Y. Yamamoto, M. Tsubaki, T. Takeda, T. Matsuda, K. Kishimoto and S. Nishida
Minodronate and statins induce apoptosis of osteosarcoma cells via suppressing K-Ras activation, Akt, mTOR, and ERK1/2 phosphorylation and enhancing expression of Bim
W. Li, Z. Yang, L. Ding, Y. Wang, X. Zhao, J. Chu, Q. Ji, M. Yao and J. Wang
A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer
K. Kreft, T. Stanić, P. Perhavec, R. Dreu and Z. Lavrič
Influence of fused deposition modelling printing parameters on tablet disintegration times: a design of experiments study
F. N. Eze, C. Jansakul and T. Srichana
Insights into the formulation properties, biocompatibility, and permeability of poorly water-soluble methoxyflavones with PEG400 and propylene glycol